Is GRCL or QYLD a better dividend investment in 2026?

GRCL currently yields 19.51% with a 5% 5-year dividend growth rate. QYLD yields 12.24% with -2.1% growth. The better choice depends on your goal: GRCL offers higher current income.

What is the dividend yield difference between GRCL and QYLD?

GRCL has a forward dividend yield of 19.51% ($2.00/share annually). QYLD yields 12.24% ($2.04/share annually). The yield gap is 7.27 percentage points.

Home › Compare › GRCL vs QYLD

GRCL vs QYLD: Dividend Comparison 2026

GRCL yields 19.51% · QYLD yields 12.24%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GRCL wins by $44.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

GRCL

● Live price

19.51%

Share price

$10.25

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$70.9K

Annual income

$6,394.90

Full GRCL calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

12.24%

Share price

$16.70

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.5K

Annual income

$6,038.84

Full QYLD calculator →

Portfolio growth — GRCL vs QYLD

📍 GRCL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GRCL	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GRCL + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GRCL pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRCL

Annual income on $10K today (after 15% tax)

$1,658.54/yr

After 10yr DRIP, annual income (after tax)

$5,435.67/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,040.82/yr

After 10yr DRIP, annual income (after tax)

$5,133.01/yr

At 15% tax rate, GRCL beats the other by $302.65/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRCL + QYLD for your $10,000?

GRCL: 50%QYLD: 50%

100% QYLD50/50100% GRCL

Portfolio after 10yr

$48.7K

Annual income

$6,216.87/yr

Blended yield

12.76%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GRCL right now

GRCL

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$6.00

-41.5% upside vs current

Range: $6.00 — $6.00

Altman Z

1.5

Piotroski

3/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRCL buys

QYLD buys

No recent congressional trades found for GRCL or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGRCLQYLD

Forward yield	19.51% ✓	12.24%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$70.9K ✓	$26.5K
Annual income after 10y	$6,394.90 ✓	$6,038.84
Total dividends collected	$39.8K ✓	$28.5K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: GRCL vs QYLD ($10,000, DRIP)

Year	GRCL Portfolio	GRCL Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$12,651	$1,951.22	$10,384	$1,224.49	+$2.3K → GRCL
2	$15,844	$2,307.04	$10,900	$1,388.18	+$4.9K → GRCL
3	$19,653	$2,700.22	$11,576	$1,590.76	+$8.1K → GRCL
4	$24,159	$3,130.30	$12,447	$1,844.20	+$11.7K → GRCL
5	$29,447	$3,596.27	$13,567	$2,164.97	+$15.9K → GRCL
6	$35,604	$4,096.58	$15,003	$2,576.05	+$20.6K → GRCL
7	$42,726	$4,629.21	$16,853	$3,110.04	+$25.9K → GRCL
8	$50,908	$5,191.72	$19,251	$3,813.85	+$31.7K → GRCL
9	$60,253	$5,781.31	$22,390	$4,756.08	+$37.9K → GRCL
10	$70,866	$6,394.90	$26,548	$6,038.84	+$44.3K → GRCL

GRCL vs QYLD: Complete Analysis 2026

GRCL — Stock

Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019F, a FasTCAR-enabled CD19-directed autologous CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult B cell acute lymphoblastic leukemia (B-ALL), as well as in preclinical stage for the treatment of relapsed or refractory (r/r) B cell non-Hodgkin's lymphoma (B-NHL); and GC027, a TruUCAR-enabled CD7-directed allogeneic CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult T cell acute lymphoblastic leukemia. The company's product candidates also comprise GC007g, a donor-derived CD19-directed allogeneic CAR-T cell therapy that is in Phase 1/2 registrational trial clinical trial for the treatment of r/r B-ALL; and GC502, a TruUCAR-enabled dual CD19- and CD7 -directed, off-the-shelf allogeneic CAR-T product candidate, which is in Phase I trial for the treatment of B-cell malignancies. In addition, it has a portfolio of earlier stage product candidates targeting various cancer indications, such as ovarian cancer, breast cancer, peripheral T cell lymphoma, a subtype of NHL, and T cell lymphoblastic leukemia. The company was founded in 2017 and is headquartered in Suzhou, China.

Full GRCL Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this GRCL vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRCL vs SCHD GRCL vs JEPI GRCL vs O GRCL vs KO GRCL vs MAIN GRCL vs XYLD GRCL vs JEPQ GRCL vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.